MindWalk Holdings Corp.
Price
Key statistics
- Forward rate
- $0.00
- Yield
- 0.00%
- Payout ratio
- 0.00%
- Frequency
- Unknown
MindWalk Holdings Corp. is a pioneering bio-native artificial intelligence company specializing in the acceleration of drug discovery and development. Established in 1983, the company integrates cutting-edge AI, multi-omics data, and laboratory research through its proprietary LensAI platform and patented HYFT technology. This comprehensive platform unifies biological sequence, structure, and function data with scientific literature, facilitating rapid epitope mapping, de novo molecular design, and in silico vaccine exploration. MindWalk collaborates with pharmaceutical and biotechnology partners to streamline biologics development, reduce drug development risks, and expand therapeutic possibilities. With subsidiaries across North America and Europe, the company operates at the intersection of AI and life sciences, driving innovations in biologics discovery from target identification to clinical applications, thereby playing an influential role in the healthcare and pharmaceutical sectors.
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Dr. Jennifer Lynne Bath Ph.D.
- Employees
- 72
- Headquarters
- Austin, TX, United States
- Website
- www.ipatherapeutics.com